Cytomegalovirus resistance in transplant patients Review
<p>CMV is a major cause of disease and mortality in patients undergoing Solid Organ Transplants (SOT) and Hematopoietic Stem Cell Transplants (HSCT). In SOT, CMV infection usually establishes itself in the first three months after transplantation in patients who do not receive prophylaxis.<...
Saved in:
Main Author: | David Tarragó (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Clinical Virology - Peertechz Publications,
2023-10-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytomegalovirus in children undergoing haematopoietic stem cell transplantation: a diagnostic and therapeutic approach to antiviral resistance
by: Jocelyn Hume, et al.
Published: (2023) -
Cytomegalovirus induced pseudotumor of the colon in a renal transplanted patient
by: Syed Mudassir Laeeq, et al.
Published: (2017) -
Case Report: Approaches for managing resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplantation recipients
by: Eunkyung Song, et al.
Published: (2024) -
Seroprevalence for Human Cytomegalovirus in samples from dialysis and kidney transplanted patients
by: Patricia Okubo, et al.
Published: (2014) -
Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
by: Doesch AO, et al.
Published: (2012)